Spectrum of hantavirus infection: Hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome

Annual Review of Medicine

Volumn 50, Issue , 1999, Pages 531-545

  Peters, C J ^a   Simpson, Gary L ^b   Levy, H ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Acute renal failure; Acute respiratory distress syndrome; Bunyaviridae; Shock; Vascular leak syndrome

Indexed keywords

DOBUTAMINE; DOPAMINE; GAMMA INTERFERON; NORADRENALIN; RIBAVIRIN; TUMOR NECROSIS FACTOR;

BLOOD VESSEL PERMEABILITY; CLINICAL FEATURE; GEOGRAPHIC DISTRIBUTION; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; IMMUNOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TUBULE NECROSIS; LUNG EDEMA; LUNG ENDOTHELIUM; PHYLOGENY; PRIORITY JOURNAL; RETROPERITONEUM; REVIEW; RODENT; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS HEMORRHAGIC FEVER;

ANIMALS; CAPILLARY PERMEABILITY; CARDIOMYOPATHIES; ENDOTHELIUM, VASCULAR; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; HYPOTENSION; INFLAMMATION MEDIATORS; INTERFERON TYPE II; KIDNEY TUBULAR NECROSIS, ACUTE; LUNG; PHYLOGENY; PULMONARY EDEMA; RETROPERITONEAL SPACE; RODENTIA; SHOCK; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032980319     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.531     Document Type: Review

References (69)

1. 1. Smorodintsev AA, Kazbintsev LI, Chudakov VG. 1964. Virus Hemorrhagic Fevers. Jerusalem: Isr. Prog. Sci. Transl. 245 pp.
2. 2. Lee H, Lee P, Johnson K. 1978. Isolation of the etiologic agent of Korean hemorrhagic fever. J. Infect. Dis. 137: 298-308
3. 3. French GR, Foulke RS, Brand OA, et al. 1981. Korean hemorrhagic fever: propagation of the etiologic agent in a cell line of human origin. Science 211:1046-48
4. 4. Schmaljohn C, Hasty S, Dalrymple J, et al. 1985. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 227: 1041-44
5. 5. Nichol ST, Spiropoulou CF, Morzunov S, et al. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262 (5135):914-17
6. 6. Peters CJ. 1998. Hantavirus pulmonary syndrome in the Americas. In Emerging Infections II, ed. WM Scheld, WA Craig, JM Hughes, pp. 17-64. Washington, DC: ASM Press
7. 7. Peters CJ, Mills JN, Spiropoulou C, et al. 1998. Hantaviruses. In Tropical Infectious Diseases: Principles, Pathogens, & Practice, ed. RL Guerrant, DH Walker, PF Weller. New York: Saunders. In press
8. 8. Tsai TF. 1987. Hemorrhagic fever with renal syndrome: mode of transmission to humans. Lab. Anim. Sci. 37(4):428-30
9. 9. Antoniadis A, Stylianakis A, Papa A, et al. 1996. Direct genetic detection of Dobrava virus in Greek and Albanian haemorrhagic fever with renal syndrome (HFRS) patients. J. Inf. Dis. 174:407-10
10. 10. Glass GE, Watson AJ, LeDuc JW, Childs JE. 1994. Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron 68: 48-51
11. 11. Glass GE, Watson AJ, LeDuc JW, et al. 1993. Infection with a ratborne hantavirus in US residents is consistently associated with hypertensive renal disease. J. Infect. Dis. 167(3):614-20
12. 12. Carle DP, ed. 1954. Symposium on epidemic hemorrhagic fever. Am. J. Med. 16:617-709
13. 13. Van Ypersele de Strihou C, Mery JP. 1989. Hantavirus-related acute interstitial nephritis in western Europe. Expansion of a world-wide zoonosis. Q. J. Med. 73: 941-50
14. 14. Lee M, Kim BK, Kim S, et al. 1989. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever). Rev. Infect. Dis. 11(Suppl. 4): S877-83
15. 15. Ahlm C, Linden C, Linderholm M, et al. 1998. Central nervous system and ophthalmic involvement in nephropathia epidemica (European type of haemorrhagic fever with renal syndrome). J. Infect. 36: 149-55
16. 16. Cohen MS, Kwei HE, Chin CC, Ge HC. 1983. CNS manifestations of epidemic hemorrhagic fever. Arch. Intern. Med. 143:2070-72
17. 17. Bruno P, Hassell LH, Brown J, et al. 1990. The protean manifestations of hemorrhagic fever with renal syndrome. A retrospective review of 26 cases from Korea. Ann. Int. Med. 113:385-91
18. 18. Lähdevirta J. 1971. Nephropathia epidemica in Finland. Ann. Clin. Res. 3(Suppl. 8):1-154
19. 19. Settergren B, Juto P, Trollfors B, et al. 1989. Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev. Infect. Dis. 11: 921-27
20. 20. Kim YS, Ahn C, Han JS, et al. 1995. Hemorrhagic fever with renal syndrome caused by the Seoul virus. Nephron 71: 419-27
21. 21. Colson P, Damoiseaux PH, Brisbois J, et al. 1995. Epidemie d'hantavirose dans l'Entre-Sambre-et-Meuse, années 1992-1993. Données cliniques et biologiques. Acta Clin. Belgica 50(4):197-206
22. 22. Huggins JW, Hsiang CM, Cosgriff TM, et al. 1991. Prospective, double-blínd, concurrent, placebo controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis. 164:1119-27
23. 23. Khan AS, Spiropoulou CS, Morzunov S, et al. 1995. A fatal illness associated with a new hantavirus in Louisiana. J. Med. Virol. 46:281-86
24. 24. Khan AS, Gaviria M, Rollin PE, et al. 1966. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am. J. Med. 100:46-18
25. 25. Hjelle B, Goade D, Torrez-Martinez N, et al. 1996. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin. Infect. Dis. 23(3):495-500
26. 26. Torrez-Martinez N, Bharadwaj M, Goade D, et al. 1998. Virus-associated hantavirus pulmonary syndrome in eastern Texas: identification of the rice rat, Oryzomys palustris, as reservoir host. Emerg. Infect. Dis. 4(1):105-11
27. 27. Wells RM, Sosa ES, Yadon ZE, et al. 1997. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerg. Infect. Dis. 3: 171-74
28. 28. Padula PJ, Edelstein A, Miguel SD, et al. 1998. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241(2):323-30
29. 29. Wells RM, Young J, Williams RJ, et al. 1997. Hantavirus transmission in the United States. Emerg. Infect. Dis. 3: 361-65
30. 30. Duchin JS, Koster F, Peters CJ, et al. 1994. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N. Engl. J. Med. 330:949-55
31. 31. Moolenaar RL, Dalton C, Lipman HB, et al. 1995. Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses. Clin. Infect. Dis. 21:643-49
32. 32. Hallin G, Simpson S, Cromwell R, et al. 1996. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit. Care Med. 24:252-58
33. 33. Koster FT, Jenison SA. 1998. Hantaviruses. In Infectious Diseases, ed. SL Gorbach, JG Bartlett, NR Blacklow, pp. 2140-47. Philadelphia: Saunders. 2nd ed.
34. 34. Ketai LH, Williamson MR, Telepak RJ, et al. 1994. Hantavirus pulmonary syndrome (HPS): radiographic findings in 16 patients. Radiology 191(3):665-68
35. 35. Goade DE, Koster FT, Mertz GJ, et al. Preliminary evidence for pulmonary dysfunction in survivors of hantavirus pulmonary syndrome. Int. Conf. HFRS and Hantaviruses, 4th, Atlanta, p. 35 (Abstr).
36. 36. Chapman LE, Mertz G, Khan AS, et al. 1994. The Ribavirin Study Group. Open label intravenous ribavirin for hantavirus pulmonary syndrome. Presented at Annu. Intersci. Conf. Antimicrob. Agents Chemother., 34th, Oct. 4-7, Orlando, FL (Abstr. H-111)
37. 37. Crowley MR, Katz RW, Kessler R, et al. 1998. Successful treatment of adults with severe hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit. Care Med. 26(2):409-14
38. 38. Centers for Disease Control. 1998. Hantavirus pulmonary syndrome - Colorado and New Mexico, 1998. MMWR 47: 449-52
39. 39. Simpson GL. 1998. Vector-borne and animal-associated infections. In Infectious Disease in Emergency Medicine, ed. JC Brillman, RW Quenzer, pp. 209-29. Philadelphia: Lippincott-Raven. 2nd ed.
40. 40. Doyle TJ, Bryan RT, Peters CJ. 1998. Viral hemorrhagic fevers and hantavirus infections in the Americas. Infect. Dis. Clin. No. Am. 12:95-110
41. 41. Ksiazek TG, Peters CJ, Rollin PE, et al. 1995. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am. J. Trop. Med. Hyg. 52:117-23
42. 42. Yanigahara R, Silverman DJ. 1990. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch. Virol. 111:281-86
43. 43. Sundstrom JB, Mahanty S, Spiropoulou DF, et al. 1998. Comparison of the direct effects of Sin Nombre (SNV) and Hantaan (HTN) virus infection on the activation of human lung microvascular endothelial cells (HMVEC-L) in vitro. Presented at Int. Conf. HFRS and Hantaviruses, 4th, March 5-7, Atlanta, p. 44 (Abstr.)
44. 44. Zaki SR, Greer PW, Coffield LM, et al. 1995. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am. J. Pathol. 146:552-79
45. 45. Nolte KB, Feddersen RM, Foucar K, et al. 1995. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum. Pathol. 26(1 ):110-20
46. 46. Simpson SQ, Mapel V, Koster FT, et al. 1995. Evidence for lymphocyte activation in the hantavirus pulmonary syndrome. Chest 108:97S
47. 47. Simpson SQ, Mapel V, Koster FT, et al. 1996. Evidence for tumor necrosis factor activation in the hantavirus pulmonary syndrome. Crit. Care Med. 24:A26
48. 48. Ennis FA, Cruz J, Spiropoulou CF, et al. 1997. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 238:380-90
49. 49. Peters CJ. 1997. Pathogenesis of viral hemorrhagic fevers. In Viral Pathogenesis, ed. N Nathanson, R Ahmed, F Gonzalez-Scarano, et al, pp. 779-99. Philadelphia: Lippincott-Raven
50. 50. Gavrilovskaya IN, Shepley M, Shaw R, et al. 1998. Beta3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. USA 95:7074-79
51. 51. Sirotin VZ, Obukhova GG, Mogila TV. 1981. Kallikrein-kinin coagulation and fibrinolytic blood system in patients suffering from hemorrhagic fever with renal syndrome. Terapevticheskii Ark. 53(9): 84-87
52. 52. Yan D, Gu X, Daoqin W, Yang S. 1981. Studies on immunopathogenesis in epidemic hemorrhagic fever: sequential observations on activation of the first complement component in sera from patients with epidemic hemorrhagic fever. J. Immunol. 127:1064-69
53. 53. Zaki SR. 1996. Hantavirus-associated diseases. In Diagnostic Pathology of Infectious Diseases, ed. DH Connor, DA Schwartz, FW Chandler, pp. 125-136. Stamford, CT: Appleton & Lange
54. 54. Entwisle GM, Hale EH. 1957. Hemodynamic alterations in hemorrhagic fever. Circulation 15:414-25
55. 55. Linderholm M, Sandstrom T, Rinnstrom O, et al. 1997. Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 25: 1084-89
56. 56. Clement J, Colson P, McKenna P. 1994. Hantavirus pulmonary syndrome in New England and Europe. N. Engl. J. Med. 331:545-46
57. 57. LeDuc JW, Ksiazek TG, Rossi CA, Dalrymple JM. 1990. A retrospective analysis of sera collected by the Hemorrhagic Fever Commission during the Korean Conflict. J. Infect. Dis. 162(5):1182-84
58. 58. Lewis RM, Lee HW, See AF, et al. 1991. Changes in populations of immune effector cells during the course of haemorrhagic fever with renal syndrome. Trans. R. Soc. Trop. Med. Hyg. 85:282-86
59. 59. Ramsay AJ, Ruby J, Ramshaw IA. 1993. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14:155-57
60. 60. Yang CW, Bang BK. 1992. Changes of serum levels of tumor necrosis factor-alpha in patients with hemorrhagic fever with renal syndrome. J. Cathol. Med. Coll. 45:819-30
61. 61. Linderholm M, Ahlm C, Settergren B, et al. 1996. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173(1): 38-43
62. 62. Temonen M, Mustonen J, Helin H, et al. 1996. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin. Immunol. Immunopathol. 78:47-55
63. 63. Mustonen J, Partanen J, Kanerva M, et al. 1996. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 49(1): 217-21
64. 64. Plyusnin A, Horling J, Kanerva M, et al. 1997. Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J. Clin. Microbiol. 35(5): 1090-96
65. 65. Mustonen J, Partanen J, Kanerva M, et al. 1998. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand. J. Immunol. 47(3):277-79
66. 66. Feldmann H, Sanchez A, Morzunov S, et al. 1993. Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res. 30:351-67
67. 67. Niklasson B, Kjelsson T. 1988. Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 26(8):1519-23
68. 68. Hjelle B, Spiropoulou CF, Torrez-Martinez N, et al. 1994. Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. J. Infect. Dis. 170:1013-17
69. 69. Hjelle B, Jenison S, Torrez-Martinez N, et al. 1997. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J. Clin. Microbiol. 35(3): 600-8